Budget Impact Analysis Of Biosimilar Infliximab For The Treatment Of Crohn's Disease In Six Central Eastern European Countries
- PMID: 27200752
- DOI: 10.1016/j.jval.2014.08.805
Budget Impact Analysis Of Biosimilar Infliximab For The Treatment Of Crohn's Disease In Six Central Eastern European Countries
LinkOut - more resources
Full Text Sources
Other Literature Sources
